Metropolitan Life Insurance Company (MetLife)’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,830
Closed -$133K 1411
2024
Q1
$133K Sell
4,830
-251
-5% -$6.91K 0.01% 903
2023
Q4
$155K Hold
5,081
0.01% 862
2023
Q3
$161K Buy
5,081
+263
+5% +$8.32K 0.01% 779
2023
Q2
$196K Buy
4,818
+344
+8% +$14K 0.01% 687
2023
Q1
$167K Sell
4,474
-777
-15% -$29K 0.01% 738
2022
Q4
$183K Buy
5,251
+703
+15% +$24.5K 0.01% 753
2022
Q3
$255K Hold
4,548
0.01% 597
2022
Q2
$235K Buy
4,548
+176
+4% +$9.11K 0.01% 641
2022
Q1
$318K Sell
4,372
-13,338
-75% -$969K 0.01% 628
2021
Q4
$2.09M Sell
17,710
-377
-2% -$44.6K 0.03% 504
2021
Q3
$2.43M Buy
18,087
+643
+4% +$86.3K 0.04% 418
2021
Q2
$2.82M Buy
17,444
+2,700
+18% +$437K 0.04% 373
2021
Q1
$1.18M Buy
14,744
+739
+5% +$59.3K 0.02% 831
2020
Q4
$762K Buy
14,005
+234
+2% +$12.7K 0.01% 1076
2020
Q3
$274K Hold
13,771
﹤0.01% 1596
2020
Q2
$289K Buy
13,771
+1,634
+13% +$34.3K 0.01% 1572
2020
Q1
$148K Sell
12,137
-2,305
-16% -$28.2K ﹤0.01% 1775
2019
Q4
$212K Sell
14,442
-1,248
-8% -$18.3K ﹤0.01% 1883
2019
Q3
$209K Buy
15,690
+4,574
+41% +$61.1K ﹤0.01% 1845
2019
Q2
$182K Hold
11,116
﹤0.01% 1948
2019
Q1
$190K Hold
11,116
﹤0.01% 1930
2018
Q4
$152K Hold
11,116
﹤0.01% 1999
2018
Q3
$318K Hold
11,116
0.01% 1687
2018
Q2
$304K Buy
11,116
+5,464
+97% +$149K ﹤0.01% 1650
2018
Q1
$119K Hold
5,652
﹤0.01% 2200
2017
Q4
$109K Sell
5,652
-5,364
-49% -$103K ﹤0.01% 2259
2017
Q3
$274K Hold
11,016
﹤0.01% 2085
2017
Q2
$176K Buy
+11,016
New +$176K ﹤0.01% 2413
2016
Q3
Sell
-8,886
Closed -$190K 2648
2016
Q2
$190K Buy
+8,886
New +$190K ﹤0.01% 2350